Emeprev Tablets by Dechra contain maropitant citrate, a potent antiemetic approved for the prevention and treatment of vomiting in dogs, including vomiting due to motion sickness. Maropitant acts as a selective neurokinin-1 (NK1) receptor antagonist, effectively blocking substance P – a key neurotransmitter involved in the vomiting reflex. Emeprev offers a convenient, safe, and reliable alternative to other maropitant-based medications, making it an excellent choice for managing acute and travel-related nausea in dogs.

Key Features:

• Effective for prevention and treatment of acute vomiting in dogs
• Controls motion sickness-related vomiting when administered prior to travel
• Contains the same active ingredient (maropitant citrate) as Cerenia®
• Scored tablets for accurate, flexible dosing
• Cost-effective antiemetic option
• Suitable for dogs 8 weeks of age and older

Indications & Dosage:

• Acute Vomiting: Administer Emeprev orally at a minimum dose of 2 mg/kg once daily for up to 5 consecutive days.
• Motion Sickness: Administer Emeprev orally at a minimum dose of 8 mg/kg once daily for up to 2 consecutive days. Dogs should fast for 1 hour before administration. Give 2 hours before travel.

Active Ingredient: Maropitant Citrate

Tablet Strengths: Available in 16 mg, 24 mg, 60 mg, and 160 mg scored tablets

Warnings & Precautions:

• Not for human use. Keep out of reach of children.
• Use with caution in dogs with liver disease or on concurrent medications that are highly protein-bound.
• Safety not established in breeding, pregnant, or lactating dogs.
• Puppies under 11 weeks of age may be at risk of bone marrow suppression at high doses.
• Wear gloves or wash hands thoroughly after handling tablets.

Storage: Store at controlled room temperature: 68°–77°F (20°–25°C)

Manufacturer: Dechra Veterinary Products

Rx Medication Sold Only To Licensed Veterinarians & Pharmacies. Current License Must Be On File Prior To Shipping.